Loading clinical trials...
Loading clinical trials...
GALOP II Protocol for the Treatment of Unilateral Retinoblastoma
Conditions
Interventions
Combination Chemotherapy plus Intrathecal Topotecan
Higher Dose Combination Chemotherapy plus Intrathecal Topotecan
+2 more
Locations
1
Argentina
Hospital JP Garrahan
Buenos Aires, Buenos Aires F.D., Argentina
Start Date
January 1, 2018
Primary Completion Date
January 31, 2023
Completion Date
March 28, 2025
Last Updated
April 13, 2025
Lead Sponsor
Hospital JP Garrahan
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions